Skip to content
SEARCH icon
  • Investing
  • Market News
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Technology
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Market News
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Technology
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
icon

      HomeBiotech

      Biotech

      Dynavax Files Preliminary Proxy Statement
      Biotech

      Dynavax Files Preliminary Proxy Statement

      April 4, 2025
      Fangzhou Designated as a 2024 National High-Tech Enterprise Amid Record Growth
      Biotech

      Fangzhou Designated as a 2024 National High-Tech Enterprise Amid Record Growth

      April 3, 2025
      BIOPHARM WINS EXCELLENCE IN GENERIC MEDICINE DEVELOPMENT IN ALGERIA AT THE GLOBAL BRAND AWARDS 2024
      Biotech

      BIOPHARM WINS EXCELLENCE IN GENERIC MEDICINE DEVELOPMENT IN ALGERIA AT THE GLOBAL BRAND AWARDS 2024

      April 2, 2025
      IDEAYA Biosciences Announces Participation in Upcoming April 2025 Investor Relations Events
      Biotech

      IDEAYA Biosciences Announces Participation in Upcoming April 2025 Investor Relations Events

      April 1, 2025
      Akeso’s 2024 Results: Strengthening Global Competitiveness and Transforming the Treatment Landscape with Bispecific Antibodies
      Biotech

      Akeso’s 2024 Results: Strengthening Global Competitiveness and Transforming the Treatment Landscape with Bispecific Antibodies

      March 31, 2025
      Oral semaglutide 14 mg demonstrated superior reduction in risk of cardiovascular events in late-breaking SOUL trial presented at the American College of Cardiology
      Biotech

      Oral semaglutide 14 mg demonstrated superior reduction in risk of cardiovascular events in late-breaking SOUL trial presented at the American College of Cardiology

      March 30, 2025
      FDA Approves Novel Treatment for Hemophilia A or B, with or without Factor Inhibitors
      Biotech

      FDA Approves Novel Treatment for Hemophilia A or B, with or without Factor Inhibitors

      March 29, 2025
      Shanton Reveals Topline Data from Phase 2b Study in Refractory Gout Patients
      Biotech

      Shanton Reveals Topline Data from Phase 2b Study in Refractory Gout Patients

      March 28, 2025
      ARTHEx Biotech to Participate in the 24th Annual Needham Virtual Healthcare Conference
      Biotech

      ARTHEx Biotech to Participate in the 24th Annual Needham Virtual Healthcare Conference

      March 27, 2025
      Photocure appoints Jane Healy as Vice President and General Manager EMEA
      Biotech

      Photocure appoints Jane Healy as Vice President and General Manager EMEA

      March 26, 2025
      « 1 … 19 20 21 22 23 … 37 »

       

      LATEST NEWS

      • Investing News Cisco Q2 Earnings Beat, Shares Dip Despite Revenue Gains
      • Investing News Alphabet Stock Falls 7% After Q4 Earnings
      • Investing News US Stock Market Update: Gains Amid Mixed Earnings
      • Investing News McDonald’s Value Strategy Drives Sales Surge

      UpAlpha

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from UpAlpha.

      I want e-mail alerts, updates, and offers and agree to the UpAlpha privacy policy.

      Market Jar Media Inc. © 2026